UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-10-24 | Future report Set alerts | |
| Q2 2022 | 2022-08-08 | -0.84 | -0.84 |
| Q1 2022 | 2022-05-02 | -1.00 | -1.00 |
| Q4 2021 | 2022-02-25 | 0.18 | 0.18 |
| Q3 2021 | 2021-10-25 | -0.79 | -0.79 |
| Q2 2021 | 2021-07-26 | 8.51 | 8.51 |
| Q1 2021 | 2021-05-10 | -0.91 | -0.91 |
| Q4 2020 | 2021-03-01 | -0.01 | -0.01 |
| Q3 2020 | 2020-10-27 | -1.21 | -1.21 |
| Q2 2020 | 2020-07-30 | -0.96 | -0.96 |
| 2016-06-30 | Reiterated Rating | Piper Jaffray | Buy | |
| 2016-06-30 | Reiterated Rating | Piper Jaffray Cos. | Buy | |
| 2016-06-15 | Reiterated Rating | Oppenheimer | Outperform | $23.00 |
| 2016-06-15 | Lower Price Target | WallachBeth Capital | Buy | $60.00 to $35.00 |
| 2016-06-15 | Reiterated Rating | Oppenheimer Holdings Inc. | Outperform | $23.00 |
| 2016-06-14 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-06-13 | Reiterated Rating | Piper Jaffray | Buy | |
| 2016-06-12 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-06-02 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-05-31 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-05-31 | Reiterated Rating | Oppenheimer | Buy | |
| 2016-05-11 | Reiterated Rating | Chardan Capital | Buy | $35.00 |
| 2016-04-14 | Reiterated Rating | Chardan Capital | Buy | |
| 2016-04-13 | Reiterated Rating | Leerink Swann | Buy | $48.00 to $27.00 |
| 2016-04-06 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-04-05 | Reiterated Rating | Oppenheimer | Buy | $50.00 to $23.00 |
| 2016-04-05 | Reiterated Rating | Piper Jaffray | Overweight | $26.00 |
| 2016-03-24 | Reiterated Rating | HC Wainwright | Buy | $30.00 |
| 2016-03-23 | Reiterated Rating | Chardan Capital | Buy | $40.00 |
| 2016-02-24 | Reiterated Rating | HC Wainwright | Buy | $30.00 |
| 2016-01-08 | Reiterated Rating | Roth Capital | Buy | $37.00 |
| 2016-01-08 | Reiterated Rating | Leerink Swann | Outperform | $48.00 |
| 2016-01-08 | Reiterated Rating | Oppenheimer | Buy | $50.00 |
| 2016-01-08 | Reiterated Rating | Janney Montgomery Scott | Buy | |
| 2016-01-08 | Reiterated Rating | Chardan Capital | Buy | $40.00 |
| 2016-01-06 | Reiterated Rating | Piper Jaffray | Overweight | $35.00 |
| 2015-12-03 | Reiterated Rating | Jefferies Group | Buy | $40.00 to $36.00 |
| 2015-12-02 | Reiterated Rating | Chardan Capital | Buy | $40.00 |
| 2015-12-01 | Reiterated Rating | Oppenheimer | Outperform | $50.00 |
| 2015-12-01 | Boost Price Target | WallachBeth Capital | Buy | $33.00 to $60.00 |
| 2015-11-30 | Initiated Coverage | Janney Montgomery Scott | Buy | $40.00 |
| 2015-11-30 | Reiterated Rating | Piper Jaffray | Buy | $40.00 to $35.00 |
| 2015-11-30 | Reiterated Rating | Cowen and Company | Buy | |
| 2015-11-30 | Initiated Coverage | Roth Capital | Buy | $37.00 |
| 2015-10-16 | Reiterated Rating | Piper Jaffray | Overweight | $40.00 |
| 2015-10-13 | Reiterated Rating | Roth Capital | Buy | $38.00 |
| 2015-10-06 | Reiterated Rating | Leerink Swann | Outperform | |
| 2015-10-01 | Boost Price Target | Chardan Capital | Buy | $35.00 to $40.00 |
| 2015-09-28 | Reiterated Rating | Roth Capital | Buy | |
| 2015-09-24 | Reiterated Rating | HC Wainwright | Buy | $39.00 |
| 2015-09-22 | Reiterated Rating | Oppenheimer | Buy | |
| 2015-09-21 | Reiterated Rating | Leerink Swann | Outperform | $44.00 to $48.00 |
| 2015-09-21 | Reiterated Rating | Piper Jaffray | Buy | |
| 2015-09-21 | Reiterated Rating | Roth Capital | Buy | $38.00 |
| 2015-09-21 | Boost Price Target | Oppenheimer | Outperform | $47.00 to $50.00 |
| 2015-09-16 | Reiterated Rating | Chardan Capital | Buy | |
| 2015-09-08 | Reiterated Rating | Roth Capital | Buy | $38.00 |
| 2015-08-31 | Reiterated Rating | Roth Capital | Buy | |
| 2015-08-28 | Reiterated Rating | Piper Jaffray | Buy | $40.00 |
| 2015-08-28 | Lower Price Target | Leerink Swann | Outperform | $50.00 to $44.00 |
| 2015-08-28 | Lower Price Target | WallachBeth Capital | Buy | $35.00 to $33.00 |
| 2015-08-27 | Reiterated Rating | Chardan Capital | Buy | $40.00 to $35.00 |
| 2015-08-17 | Reiterated Rating | Roth Capital | Buy | |
| 2015-08-12 | Reiterated Rating | Oppenheimer | Outperform | $47.00 |
| 2015-08-11 | Reiterated Rating | Piper Jaffray | Buy | |
| 2015-08-07 | Initiated Coverage | WallachBeth Capital | Buy | $35.00 |
| 2015-07-16 | Reiterated Rating | Roth Capital | Buy | $38.00 |
| 2015-07-15 | Initiated Coverage | Cowen and Company | Outperform | |
| 2015-07-06 | Reiterated Rating | Roth Capital | Buy | $38.00 |
| 2015-06-22 | Reiterated Rating | Oppenheimer | Outperform | $47.00 |
| 2015-06-12 | Set Price Target | Piper Jaffray | Buy | $40.00 |
| 2015-06-08 | Reiterated Rating | Roth Capital | Buy | $38.00 |
| 2015-05-22 | Initiated Coverage | Oppenheimer | Outperform | $47.00 |
| 2015-05-19 | Reiterated Rating | Roth Capital | Buy | $38.00 |
| 2015-05-09 | Reiterated Rating | BMO Capital Markets | Outperform to Positive | |
| 2015-05-06 | Reiterated Rating | Piper Jaffray | Overweight | $40.00 |
| 2015-04-24 | Initiated Coverage | Chardan Capital | Buy | $40.00 |
| 2015-04-22 | Initiated Coverage | BMO Capital Markets | Outperform | $49.00 |
| 2015-04-14 | Initiated Coverage | Roth Capital | Buy | $38.00 |
| 2015-04-07 | Boost Price Target | Leerink Swann | Outperform | $50.00 |
| 2015-04-07 | Boost Price Target | HC Wainwright | Buy | $39.00 |
| 2015-04-07 | Boost Price Target | Jefferies Group | Buy | $20.00 to $42.00 |
| 2015-04-06 | Set Price Target | Piper Jaffray | Buy | $40.00 |
| 2015-03-02 | Initiated Coverage | HC Wainwright | Buy | $30.00 |
| 2014-09-03 | Reiterated Rating | Jefferies Group | Buy | $23.00 to $22.00 |
| 2014-03-03 | Initiated Coverage | Raymond James | Market Perform | |
| 2014-03-03 | Initiated Coverage | William Blair | Market Perform | |
| 2014-03-03 | Initiated Coverage | Leerink Swann | Outperform | $25.00 |
| 2014-03-03 | Initiated Coverage | Piper Jaffray | Overweight | $35.00 |
| 2014-03-03 | Initiated Coverage | Jefferies Group | Buy | $24.00 |
| 2016-06-30 | Reiterated Rating | Piper Jaffray | Buy | |
| 2016-06-30 | Reiterated Rating | Piper Jaffray Cos. | Buy | |
| 2016-06-15 | Reiterated Rating | Oppenheimer | Outperform | $23.00 |
| 2016-06-15 | Lower Price Target | WallachBeth Capital | Buy | $60.00 to $35.00 |
| 2016-06-15 | Reiterated Rating | Oppenheimer Holdings Inc. | Outperform | $23.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In QURE 125 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 4.90M |
| Point72 Asset Management, L.P. | 4.26M |
| Nantahala Capital Management, LLC | 3.90M |
| STATE STREET CORP | 3.06M |
| FMR LLC | 2.72M |
| Partner Fund Management, L.P. | 2.39M |
| OPPENHEIMER FUNDS INC | 1.82M |
| ORBIMED ADVISORS LLC | 1.60M |
| Vanguard Group, Inc | 1.43M |
| 683 Capital Management, LLC | 1.37M |
| MORGAN STANLEY | 0.99M |
| JPMORGAN CHASE & CO | 0.73M |
| MACQUARIE GROUP LTD | 0.71M |
| Tekla Capital Management LLC | 0.52M |
| AMERIPRISE FINANCIAL INC | 0.51M |
UM